KOPRAN Financial Statement Analysis
|
||
|
The Revenues of KOPRAN have increased by 8.23% YoY .
The Earnings Per Share (EPS) of KOPRAN has decreased by -33.21 % YoY. |
||
KOPRAN Last 5 Annual Financial Results
[BOM: 524280|NSE : KOPRAN]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹681 Cr | ₹630 Cr | ₹615 Cr | ₹551 Cr | ₹478 Cr |
| Expenses | ₹619 Cr | ₹557 Cr | ₹540 Cr | ₹499 Cr | ₹390 Cr |
| Operating Profit (Excl OI) | ₹62 Cr | ₹73 Cr | ₹74 Cr | ₹52 Cr | ₹87 Cr |
| Other Income | ₹0.35 Cr | ₹3.98 Cr | ₹15 Cr | ₹3.07 Cr | ₹11 Cr |
| Interest | ₹10 Cr | ₹9.34 Cr | ₹8.59 Cr | ₹6.08 Cr | ₹5.12 Cr |
| Depreciation | ₹17 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr | ₹11 Cr |
| Profit Before Tax | ₹34 Cr | ₹52 Cr | ₹68 Cr | ₹36 Cr | ₹82 Cr |
| Profit After Tax | ₹26 Cr | ₹39 Cr | ₹51 Cr | ₹27 Cr | ₹61 Cr |
| Consolidated Net Profit | ₹26 Cr | ₹39 Cr | ₹51 Cr | ₹27 Cr | ₹61 Cr |
| Earnings Per Share (Rs) | ₹5.33 | ₹7.98 | ₹10.57 | ₹5.65 | ₹12.66 |
| PAT Margin (%) | 3.78 | 6.12 | 8.29 | 4.88 | 12.60 |
| ROE(%) | 4.92 | 7.66 | 10.96 | 6.29 | 18.19 |
| ROCE(%) | 6.65 | 9.75 | 13.78 | 8.30 | 21.40 |
| Total Debt/Equity(x) | 0.29 | 0.29 | 0.20 | 0.17 | 0.17 |
Key Financials |
||
| Market Cap | : | ₹ 912.1 Cr |
| Revenue (TTM) | : | ₹ 681.4 Cr |
| Net Profit(TTM) | : | ₹ 25.7 Cr |
| EPS (TTM) | : | ₹ 5.3 |
| P/E (TTM) | : | 35.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KOPRAN | -5.1% | -2.9% | 11% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | 2.4% | 17.1% |
| DIVIS LABORATORIES | 12.2% | 23.1% | 21.7% |
| TORRENT PHARMACEUTICALS | 2.4% | 5.3% | 41.7% |
| CIPLA | 1.7% | 0.7% | -3.8% |
| DR REDDYS LABORATORIES | 3% | -14.9% | -10.2% |
| MANKIND PHARMA | -5.5% | -2.2% | -5.1% |
| LUPIN | -0.8% | -4% | 23.7% |
| ZYDUS LIFESCIENCES | 1.5% | -2.2% | 15.3% |
KOPRAN Revenues
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | 8.23 % |
| 5 Yr CAGR | 9.30 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹681 Cr | 8.23 | |
| Mar2025 | ₹630 Cr | 2.44 | |
| Mar2024 | ₹615 Cr | 11.54 | |
| Mar2023 | ₹551 Cr | 15.38 | |
| Mar2022 | ₹478 Cr | - | |
KOPRAN Operating Profit
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | -15.01 % |
| 5 Yr CAGR | -8.20 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹62 Cr | -15.01 | |
| Mar2025 | ₹73 Cr | -1.96 | |
| Mar2024 | ₹74 Cr | 43.56 | |
| Mar2023 | ₹52 Cr | -40.63 | |
| Mar2022 | ₹87 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -21.50 % |
| 5 Yr CAGR | -16.01 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 9.09% | -21.50 | |
| Mar2025 | 11.58% | -4.30 | |
| Mar2024 | 12.1% | 28.72 | |
| Mar2023 | 9.4% | -48.55 | |
| Mar2022 | 18.27% | - | |
KOPRAN Profit After Tax
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | -33.26 % |
| 5 Yr CAGR | -19.42 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹26 Cr | -33.26 | |
| Mar2025 | ₹39 Cr | -24.34 | |
| Mar2024 | ₹51 Cr | 87.11 | |
| Mar2023 | ₹27 Cr | -55.38 | |
| Mar2022 | ₹61 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -38.24 % |
| 5 Yr CAGR | -25.99 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 3.78 % | -38.24 | |
| Mar2025 | 6.12 % | -26.18 | |
| Mar2024 | 8.29 % | 69.88 | |
| Mar2023 | 4.88 % | -61.27 | |
| Mar2022 | 12.6 % | - | |
KOPRAN Earnings Per Share (EPS)
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | -33.21 % |
| 5 Yr CAGR | -19.45 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.33 | -33.21 | |
| Mar2025 | ₹7.98 | -24.50 | |
| Mar2024 | ₹11 | 87.08 | |
| Mar2023 | ₹5.65 | -55.37 | |
| Mar2022 | ₹13 | - | |
KOPRAN Return on Capital Employed (ROCE)
[BOM: 524280|NSE : KOPRAN]
| Y-o-Y | -31.79 % |
| 5 Yr CAGR | -25.34 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 6.65% | -31.79 | |
| Mar2025 | 9.75% | -29.25 | |
| Mar2024 | 13.78% | 66.02 | |
| Mar2023 | 8.3% | -61.21 | |
| Mar2022 | 21.4% | - | |
KOPRAN Share Price vs Sensex
| Current Share Price | : | ₹188.9 |
| Current MarketCap | : | ₹ 912.1 Cr |
| Updated EOD on | : | Aug 03,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -5.1% |
-2.9% |
11% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
KOPRAN related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 1.1% | 2.7% | 12.2% |
No NSE index found
You may also like the below Video Courses
FAQ about KOPRAN Financials
How the annual revenues of KOPRAN have changed ?
The Revenues of KOPRAN have increased by 8.23% YoY .
How the Earnings per Share (EPS) of KOPRAN have changed?
The Earnings Per Share (EPS) of KOPRAN has decreased by -33.21 % YoY .
Check out Intrinsic Value of Peers of KOPRAN
Compare Stock Analytics of Peers of KOPRAN
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
